Drug discovery company focused on developing pharmaceutical products targeting G-protein coupled receptors (GPCRs).
At Trevena, our mission is to deliver innovative solutions to patients and healthcare providers confronting serious medical conditions.
- Founded in 2007
- Publicly Traded (NASDAQ: TRVN)
- Headquarters: King of Prussia, PA
Our history is rooted in strong science – Trevena was founded to translate Nobel Prize-winning research into a new generation of groundbreaking medicines. Our novel approach to drug discovery has established us as pioneers in acute care medicine.